Nuclear localization of S100A4 protein could therefore be an indicator for poor prognosis of ovarian cancer and S100A4 might be an important autocrine/paracrine factor involved in the aggressive behavior of ovarian cancer cells, which could be further developed as a therapeutic target to control ovarian cancer metastasis [73]. The gene discussed is S100A4; the disease is ovarian carcinoma.